Literature DB >> 16167008

Albumin-bound nanoparticle paclitaxel.

William J Gradishar1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16167008

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN: 1543-0790


× No keyword cloud information.
  5 in total

Review 1.  Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer.

Authors:  Daniel C Julien; Steven Behnke; Guankui Wang; Gordon K Murdoch; Rodney A Hill
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

2.  Advances of cancer therapy by nanotechnology.

Authors:  Xu Wang; Yiqing Wang; Zhuo Georgia Chen; Dong M Shin
Journal:  Cancer Res Treat       Date:  2009-03-31       Impact factor: 4.679

3.  Ionically fixed polymeric nanoparticles as a novel drug carrier.

Authors:  Sa-Won Lee; Dong-Hoon Chang; Myung-Seop Shim; Bong-Oh Kim; Sun-Ok Kim; Min-Hyo Seo
Journal:  Pharm Res       Date:  2007-03-23       Impact factor: 4.200

Review 4.  Frontiers in cancer nanomedicine: directing mass transport through biological barriers.

Authors:  Mauro Ferrari
Journal:  Trends Biotechnol       Date:  2010-01-14       Impact factor: 19.536

5.  Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis.

Authors:  Safaa Sebak; Maryam Mirzaei; Meenakshi Malhotra; Arun Kulamarva; Satya Prakash
Journal:  Int J Nanomedicine       Date:  2010-09-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.